Clinical Trial Update: An Investigator Initiated Study for OTOV101N+OTOV101C Injection [NA]

View source ↗

Summary

Investigator-initiated study evaluating OTOV101N plus OTOV101C injection for autosomal recessive nonsyndromic deafness 9 (DFNB9); current trial status is UNKNOW…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Recessive Nonsyndromic Deafness

Drugs mentioned

• OTOV101N+OTOV101C Injection

Snippet

Sponsor: Otovia Therapeutics | Conditions: DFNB9 | NA | Status: UNKNOWN